Functional	O
Myc-Max	B-protein
heterodimer	I-protein
is	O
required	O
for	O
activation-induced	O
apoptosis	O
in	O
T	B-cell_line
cell	I-cell_line
hybridomas	I-cell_line
.	O

T	B-cell_line
cell	I-cell_line
hybridomas	I-cell_line
respond	O
to	O
activation	O
signals	O
by	O
undergoing	O
apoptotic	O
cell	O
death	O
,	O
and	O
this	O
is	O
likely	O
to	O
represent	O
comparable	O
events	O
related	O
to	O
tolerance	O
induction	O
in	O
immature	B-cell_type
and	I-cell_type
mature	I-cell_type
T	I-cell_type
cells	I-cell_type
in	O
vivo	O
.	O

Previous	O
studies	O
using	O
antisense	O
oligonucleotides	O
implicated	O
the	O
c-Myc	B-protein
protein	I-protein
in	O
the	O
phenomenon	O
of	O
activation-induced	O
apoptosis	O
.	O

This	O
role	O
for	O
c-Myc	B-protein
in	O
apoptosis	O
is	O
now	O
confirmed	O
in	O
studies	O
using	O
a	O
dominant	O
negative	O
form	O
of	O
its	O
heterodimeric	O
binding	O
partner	O
,	O
Max	B-protein
,	O
which	O
we	O
show	O
here	O
inhibits	O
activation-induced	O
apoptosis	O
.	O

Further	O
,	O
coexpression	O
of	O
a	O
reciprocally	B-protein
mutant	I-protein
Myc	I-protein
protein	I-protein
capable	O
of	O
forming	O
functional	O
heterodimers	B-protein
with	O
the	O
mutant	O
Max	B-protein
can	O
compensate	O
for	O
the	O
dominant	O
negative	O
activity	O
and	O
restore	O
activation-induced	O
apoptosis	O
.	O

These	O
results	O
imply	O
that	O
Myc	B-protein
promotes	O
activation-induced	O
apoptosis	O
by	O
obligatory	O
heterodimerization	O
with	O
Max	B-protein
,	O
and	O
therefore	O
,	O
by	O
regulating	O
gene	O
transcription	O
.	O

Brief	NULL
Definitive	NULL
Report	NULL
Functional	NULL
Myc-Max	NULL
Heterodimer	NULL
Is	NULL
Required	NULL
for	NULL
Activation-induced	NULL
Apoptosis	NULL
in	NULL
T	NULL
Cell	NULL
Hybridomas	NULL
By	NULL
Reid	NULL
P.	NULL
Bissonnette	NULL
,	NULL
``	NULL
Anne	NULL
Artin	NULL
MahboubiÂ®	NULL
,	NULL
and	NULL
Douglas	NULL
R.	NULL
Green*	NULL
From	NULL
the	NULL
La	NULL
Jolla	NULL
Institute	NULL
for	NULL
Allergy	NULL
and	NULL
Immunology	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037	NULL
;	NULL
and	NULL
the	NULL
Cell	NULL
Biology	NULL
Laboratory	NULL
,	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
St.	NULL
Patrick	NULL
's	NULL
College	NULL
,	NULL
Maynooth	NULL
,	NULL
Ireland	NULL
Summary	NULL
T	NULL
cell	NULL
hybridomas	NULL
respond	NULL
to	NULL
activation	NULL
signals	NULL
by	NULL
undergoing	NULL
apoptotic	NULL
cell	NULL
death	NULL
,	NULL
and	NULL
this	NULL
is	NULL
likely	NULL
to	NULL
represent	NULL
comparable	NULL
events	NULL
related	NULL
to	NULL
tolerance	NULL
induction	NULL
in	NULL
immature	NULL
and	NULL
mature	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Previous	NULL
studies	NULL
using	NULL
antisense	NULL
oligonucleotides	NULL
implicated	NULL
the	NULL
c-Myc	NULL
protein	NULL
in	NULL
the	NULL
phenomenon	NULL
of	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

This	NULL
role	NULL
for	NULL
c-Myc	NULL
in	NULL
apoptosis	NULL
is	NULL
now	NULL
confirmed	NULL
in	NULL
studies	NULL
using	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
its	NULL
heterodimeric	NULL
binding	NULL
partner	NULL
,	NULL
Max	NULL
,	NULL
which	NULL
we	NULL
show	NULL
here	NULL
inhibits	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

Further	NULL
,	NULL
coexpression	NULL
of	NULL
a	NULL
reciprocally	NULL
mutant	NULL
Myc	NULL
protein	NULL
capable	NULL
of	NULL
forming	NULL
functional	NULL
heterodimers	NULL
with	NULL
the	NULL
mutant	NULL
Max	NULL
can	NULL
compensate	NULL
for	NULL
the	NULL
dominant	NULL
negative	NULL
activity	NULL
and	NULL
restore	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
Myc	NULL
promotes	NULL
activation-induced	NULL
apoptosis	NULL
by	NULL
obligatory	NULL
heterodimerization	NULL
with	NULL
Max	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
by	NULL
regulating	NULL
gene	NULL
transcription	NULL
.	NULL

igation	NULL
of	NULL
the	NULL
CD3	NULL
TCR	NULL
complex	NULL
on	NULL
mature	NULL
and	NULL
immature	NULL
T	NULL
lymphocytes	NULL
induces	NULL
extensive	NULL
gene	NULL
expression	NULL
,	NULL
including	NULL
the	NULL
early	NULL
induction	NULL
of	NULL
c-myc	NULL
.	NULL

In	NULL
immature	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell	NULL
hybridomas	NULL
this	NULL
activation	NULL
also	NULL
leads	NULL
to	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
a	NULL
manner	NULL
which	NULL
is	NULL
dependent	NULL
upon	NULL
macro-molecular	NULL
synthesis	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
used	NULL
antisense	NULL
oligodeoxynucleotides	NULL
to	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
c-Myc	NULL
in	NULL
activated	NULL
T	NULL
hybridoma	NULL
cells	NULL
.	NULL

This	NULL
treatment	NULL
leads	NULL
to	NULL
a	NULL
rapid	NULL
loss	NULL
of	NULL
c-Myc	NULL
protein	NULL
and	NULL
we	NULL
found	NULL
that	NULL
this	NULL
blocked	NULL
activation-induced	NULL
apoptosis	NULL
(	NULL
5	NULL
)	NULL
.	NULL

This	NULL
and	NULL
other	NULL
studies	NULL
(	NULL
6-9	NULL
)	NULL
have	NULL
implicated	NULL
c-Myc	NULL
in	NULL
some	NULL
forms	NULL
of	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
promoting	NULL
cell	NULL
entry	NULL
and	NULL
passage	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
c-Myc	NULL
functions	NULL
to	NULL
direct	NULL
cells	NULL
into	NULL
an	NULL
apoptotic	NULL
pathway	NULL
.	NULL

The	NULL
outcome	NULL
of	NULL
c-Myc	NULL
activation	NULL
is	NULL
likely	NULL
to	NULL
depend	NULL
upon	NULL
other	NULL
signals	NULL
,	NULL
such	NULL
as	NULL
those	NULL
provided	NULL
by	NULL
growth	NULL
factors	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
or	NULL
by	NULL
other	NULL
oncogenes	NULL
(	NULL
6	NULL
,	NULL
10-12	NULL
)	NULL
.	NULL

Myc	NULL
is	NULL
known	NULL
to	NULL
associate	NULL
with	NULL
several	NULL
proteins	NULL
within	NULL
the	NULL
cell	NULL
,	NULL
including	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
13	NULL
)	NULL
,	NULL
TFII-I	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
Max	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

This	NULL
last	NULL
protein	NULL
forms	NULL
a	NULL
heterodimer	NULL
with	NULL
Myc	NULL
which	NULL
regulates	NULL
gene	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
role	NULL
of	NULL
c-Myc	NULL
in	NULL
activation-induced	NULL
apoptosis	NULL
was	NULL
related	NULL
to	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
Myc-Max	NULL
heterodimer	NULL
in	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
,	NULL
we	NULL
have	NULL
used	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
c-Myc	NULL
and	NULL
Max	NULL
which	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
block	NULL
transcriptional	NULL
regulation	NULL
and	NULL
transformation	NULL
by	NULL
c-Myc	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Plasmids	NULL
,	NULL
Cell	NULL
Culture	NULL
,	NULL
and	NULL
Transfections	NULL
.	NULL

The	NULL
A1.1	NULL
T	NULL
cell	NULL
hybridoma	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
IMDM	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
,	NULL
5	NULL
x	NULL
10-5	NULL
M	NULL
B-mercapto-ethanol	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
elec-troporation	NULL
using	NULL
a	NULL
capacitor-discharge	NULL
pulse	NULL
generator	NULL
(	NULL
GenePulser	NULL
;	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
from	NULL
log	NULL
phase	NULL
cultures	NULL
,	NULL
suspended	NULL
in	NULL
the	NULL
original	NULL
conditioned	NULL
medium	NULL
at	NULL
10	NULL
x	NULL
105/ml	NULL
and	NULL
0.8	NULL
ml	NULL
cell	NULL
suspension	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
pug	NULL
linearized	NULL
plasmid	NULL
.	NULL

The	NULL
suspensions	NULL
were	NULL
pulsed	NULL
once	NULL
with	NULL
250	NULL
V	NULL
at	NULL
960-uF	NULL
capacitance	NULL
in	NULL
a	NULL
0.4-mm	NULL
gap	NULL
cuvette	NULL
,	NULL
and	NULL
pulsed	NULL
cells	NULL
were	NULL
incubated	NULL
a	NULL
further	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
after	NULL
which	NULL
they	NULL
were	NULL
placed	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
fresh	NULL
media	NULL
.	NULL

Transfected	NULL
cell	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
fresh	NULL
media	NULL
.	NULL

They	NULL
were	NULL
incubated	NULL
an	NULL
additional	NULL
10-14	NULL
d	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
selection	NULL
media	NULL
,	NULL
containing	NULL
either	NULL
800	NULL
pg/val	NULL
G418	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
or	NULL
500	NULL
ug/ml	NULL
hygromycin	NULL
B	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

These	NULL
bulk	NULL
transfectants	NULL
were	NULL
reselected	NULL
an	NULL
additional	NULL
10	NULL
d	NULL
in	NULL
G418	NULL
or	NULL
hygromycin	NULL
before	NULL
being	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
described	NULL
.	NULL

Alternatively	NULL
,	NULL
individual	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
limiting	NULL
dilution	NULL
growth	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
selection	NULL
antibiotics	NULL
.	NULL

The	NULL
clones	NULL
were	NULL
screened	NULL
for	NULL
gene	NULL
expression	NULL
by	NULL
reverse	NULL
transcriptase-PCR	NULL
(	NULL
cDNA	NULL
cycle	NULL
;	NULL
In-vitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
species-	NULL
and	NULL
construct-specific	NULL
primers	NULL
.	NULL

All	NULL
of	NULL
the	NULL
expression	NULL
vectors	NULL
containing	NULL
the	NULL
reciprocal	NULL
exchange	NULL
mutants	NULL
or	NULL
wild-type	NULL
mye	NULL
and	NULL
max	NULL
genes	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
constructed	NULL
and	NULL
described	NULL
by	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
myc	NULL
exchange	NULL
mutant	NULL
(	NULL
mycRX	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
helix-loop-helix	NULL
leucine	NULL
zipper	NULL
(	NULL
HLH/LZ	NULL
)	NULL
domain	NULL
of	NULL
c-Myc	NULL
with	NULL
the	NULL
complementary	NULL
domain	NULL
from	NULL
max	NULL
.	NULL

Both	NULL
c-mye	NULL
and	NULL
mycRX	NULL
were	NULL
placed	NULL
in	NULL
a	NULL
G418-selectable	NULL
retroviral	NULL
vector	NULL
.	NULL

The	NULL
max	NULL
exchange	NULL
mutant	NULL
(	NULL
maxRX	NULL
)	NULL
and	NULL
wild-type	NULL
max	NULL
were	NULL
placed	NULL
in	NULL
a	NULL
similar	NULL
but	NULL
hygromycin-selectable	NULL
retroviral	NULL
vector	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Bruno	NULL
Amati	NULL
(	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
linearized	NULL
before	NULL
transfections	NULL
.	NULL

Induction	NULL
and	NULL
Analysis	NULL
of	NULL
Apoptosis	NULL
.	NULL

-	NULL
For	NULL
the	NULL
induction	NULL
of	NULL
apop-	NULL
2413	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

Â©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
Â«	NULL
0022-1007/94/12/2413/06	NULL
$	NULL
2.00	NULL
Volume	NULL
180	NULL
December	NULL
1994	NULL
2413-2418	NULL
tosis	NULL
,	NULL
the	NULL
A1.1	NULL
T	NULL
hybridoma	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
plates	NULL
precoated	NULL
with	NULL
the	NULL
monoclonal	NULL
anti-CD3Â¢	NULL
antibody	NULL
145.2C11	NULL
(	NULL
22	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
)	NULL
.	NULL

For	NULL
direct	NULL
staining	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
to	NULL
assess	NULL
viability	NULL
,	NULL
the	NULL
contents	NULL
of	NULL
each	NULL
of	NULL
triplicate	NULL
culture	NULL
wells	NULL
were	NULL
washed	NULL
,	NULL
resuspended	NULL
in	NULL
PBS	NULL
containing	NULL
5	NULL
ug/ml	NULL
PI	NULL
,	NULL
and	NULL
analyzed	NULL
immediately	NULL
using	NULL
a	NULL
FACScanÂ®	NULL
(	NULL
log	NULL
scale	NULL
)	NULL
(	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Dead	NULL
cells	NULL
were	NULL
identified	NULL
as	NULL
those	NULL
taking	NULL
up	NULL
the	NULL
dye	NULL
.	NULL

For	NULL
analysis	NULL
by	NULL
DNA	NULL
content	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS/5	NULL
mM	NULL
EDTA	NULL
and	NULL
then	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
fixed	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
containing	NULL
100	NULL
ug/ml	NULL
RNase	NULL
A/200	NULL
U/ml	NULL
RNase	NULL
T1	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
15-30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
after	NULL
which	NULL
they	NULL
were	NULL
stained	NULL
by	NULL
adding	NULL
1	NULL
vol	NULL
PBS	NULL
containing	NULL
100	NULL
ug/ml	NULL
PI	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACScanÂ®	NULL
(	NULL
linear	NULL
scale	NULL
)	NULL
(	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
)	NULL
.	NULL

Apoptotic	NULL
cells	NULL
were	NULL
identified	NULL
by	NULL
having	NULL
less	NULL
than	NULL
2	NULL
n	NULL
DNA	NULL
content	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
sub-diploid	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
assessed	NULL
for	NULL
DNA	NULL
fragmentation	NULL
in	NULL
situ	NULL
using	NULL
a	NULL
terminal	NULL
deoxytransferase	NULL
(	NULL
TdT	NULL
)	NULL
-based	NULL
nick	NULL
end	NULL
labeling	NULL
assay	NULL
which	NULL
detects	NULL
DNA	NULL
strand	NULL
breaks	NULL
by	NULL
using	NULL
TIT	NULL
to	NULL
incorporate	NULL
biotin-labeled	NULL
UTP	NULL
,	NULL
which	NULL
is	NULL
subsequently	NULL
detected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
avidin-FITC	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
formaldehyde/PB	NULL
$	NULL
S	NULL
,	NULL
and	NULL
stored	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
.	NULL

For	NULL
UTP-biotin	NULL
incorporation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
TIT	NULL
buffer	NULL
(	NULL
0.2	NULL
M	NULL
potassium	NULL
cacodylate	NULL
,	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
6.6	NULL
,	NULL
2.5	NULL
mM	NULL
cobalt	NULL
chloride	NULL
,	NULL
0.25	NULL
mg/ml	NULL
BSA	NULL
,	NULL
100	NULL
U/ml	NULL
TIT	NULL
and	NULL
0.5	NULL
nM	NULL
biotin-16-dUTP	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
citrate/FITC-avidin	NULL
buffer	NULL
(	NULL
0.6	NULL
M	NULL
NaCl	NULL
,	NULL
0.06	NULL
M	NULL
NaCitrate	NULL
,	NULL
2.5	NULL
mg/ml	NULL
fluoresceinated	NULL
avidin	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
5	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
nonfat	NULL
dry	NULL
milk	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
analyzed	NULL
immediately	NULL
or	NULL
fixed	NULL
in	NULL
PBS/1	NULL
%	NULL
formaldehyde	NULL
for	NULL
later	NULL
analysis	NULL
.	NULL

All	NULL
FACSÂ®	NULL
data	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
LYSYS	NULL
II	NULL
software	NULL
.	NULL

For	NULL
the	NULL
quantitation	NULL
of	NULL
apoptosis	NULL
by	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
from	NULL
cultures	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
100	NULL
ul	NULL
cell	NULL
suspension	NULL
immediately	NULL
stained	NULL
with	NULL
4	NULL
ul	NULL
of	NULL
a	NULL
cocktail	NULL
of	NULL
100	NULL
ug/ml	NULL
acridine	NULL
orange	NULL
and	NULL
100	NULL
ug/ml	NULL
ethidium	NULL
bromide	NULL
in	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
scored	NULL
as	NULL
apoptotic/nonapoptotic	NULL
by	NULL
UV	NULL
light	NULL
microscopy	NULL
.	NULL

Detection	NULL
of	NULL
Lymphokine	NULL
Production	NULL
.	NULL

-	NULL
IL	NULL
2	NULL
production	NULL
was	NULL
determined	NULL
by	NULL
[	NULL
Â°H	NULL
]	NULL
JTIR	NULL
uptake	NULL
of	NULL
the	NULL
IL-2-responsive	NULL
cell	NULL
line	NULL
CTL	NULL
L	NULL
(	NULL
24	NULL
)	NULL
and	NULL
quantitated	NULL
using	NULL
a	NULL
recombinant	NULL
IL-2	NULL
standard	NULL
.	NULL

Mye	NULL
J	NULL
~	NULL
Te	NULL
__	NULL
]	NULL
Myc	NULL
E	NULL
[	NULL
6	NULL
]	NULL
I	NULL
sia	NULL
Cis	NULL
oce	NULL
]	NULL
-/	NULL
Results	NULL
and	NULL
Discussion	NULL
The	NULL
strategy	NULL
we	NULL
used	NULL
is	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
protein	NULL
composed	NULL
of	NULL
Max	NULL
with	NULL
the	NULL
HLH-LZ	NULL
of	NULL
Myc	NULL
(	NULL
MaxRX	NULL
)	NULL
forms	NULL
a	NULL
nonfunctional	NULL
dimer	NULL
with	NULL
endogenous	NULL
Max	NULL
in	NULL
the	NULL
cell	NULL
(	NULL
21	NULL
)	NULL
.	NULL

This	NULL
MaxRX-Max	NULL
dimer	NULL
acts	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
normal	NULL
Myc-Max	NULL
heterodimer	NULL
function	NULL
in	NULL
two	NULL
ways	NULL
:	NULL
not	NULL
only	NULL
does	NULL
MaxRX	NULL
bind	NULL
to	NULL
and	NULL
titrate	NULL
out	NULL
wild-type	NULL
Max	NULL
,	NULL
the	NULL
transcriptionally	NULL
inactive	NULL
Max-MaxRX	NULL
dimer	NULL
can	NULL
bind	NULL
to	NULL
DNA	NULL
and	NULL
prevent	NULL
binding	NULL
of	NULL
wild-type	NULL
Myc-Max	NULL
dimers	NULL
(	NULL
21	NULL
)	NULL
.	NULL

A	NULL
reciprocal	NULL
mutation	NULL
in	NULL
Myc	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
MycRX	NULL
,	NULL
exchanges	NULL
the	NULL
HLH-LZ	NULL
of	NULL
Myc	NULL
for	NULL
that	NULL
of	NULL
Max	NULL
.	NULL

However	NULL
,	NULL
this	NULL
molecule	NULL
might	NULL
have	NULL
only	NULL
limited	NULL
inhibitory	NULL
activity	NULL
,	NULL
since	NULL
although	NULL
MycRX	NULL
can	NULL
bind	NULL
efficiently	NULL
to	NULL
wild-type	NULL
Myc	NULL
,	NULL
the	NULL
MycRX-Myc	NULL
dimer	NULL
is	NULL
not	NULL
predicted	NULL
to	NULL
bind	NULL
efficiently	NULL
to	NULL
DNA	NULL
(	NULL
21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
both	NULL
the	NULL
inhibitory	NULL
MaxRX	NULL
and	NULL
the	NULL
MycRX	NULL
proteins	NULL
are	NULL
present	NULL
,	NULL
these	NULL
will	NULL
form	NULL
a	NULL
MycRX-MaxRX	NULL
heterodimer	NULL
that	NULL
is	NULL
functional	NULL
.	NULL

Studies	NULL
by	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
,	NULL
upon	NULL
which	NULL
this	NULL
strategy	NULL
is	NULL
based	NULL
,	NULL
showed	NULL
that	NULL
MycRX	NULL
and	NULL
MaxRX	NULL
are	NULL
both	NULL
required	NULL
for	NULL
fibroblast	NULL
transformation	NULL
,	NULL
neither	NULL
one	NULL
having	NULL
transforming	NULL
effects	NULL
on	NULL
its	NULL
own	NULL
.	NULL

Constructs	NULL
encoding	NULL
the	NULL
mutant	NULL
MaxRX	NULL
protein	NULL
were	NULL
transfected	NULL
into	NULL
A1.1	NULL
T	NULL
hybridoma	NULL
cells	NULL
and	NULL
clones	NULL
with	NULL
stable	NULL
expression	NULL
were	NULL
selected	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
examined	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
undergo	NULL
activation-induced	NULL
apoptosis	NULL
upon	NULL
exposure	NULL
to	NULL
anti-CD3	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
four	NULL
experiments	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
expression	NULL
of	NULL
MaxRX	NULL
significantly	NULL
inhibited	NULL
anti-CD3-induced	NULL
apoptosis	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
three	NULL
different	NULL
methods	NULL
.	NULL

In	NULL
the	NULL
first	NULL
,	NULL
cells	NULL
were	NULL
activated	NULL
overnight	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
without	NULL
fixation	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
FACSÂ®	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

This	NULL
simple	NULL
method	NULL
gives	NULL
an	NULL
accurate	NULL
assessment	NULL
of	NULL
cell	NULL
viability	NULL
(	NULL
since	NULL
dead	NULL
cells	NULL
take	NULL
up	NULL
the	NULL
dye	NULL
[	NULL
25	NULL
]	NULL
)	NULL
but	NULL
does	NULL
not	NULL
discriminate	NULL
between	NULL
apoptosis	NULL
and	NULL
necrosis	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
were	NULL
activated	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
to	NULL
examine	NULL
DNA	NULL
content	NULL
.	NULL

When	NULL
analyzed	NULL
by	NULL
FACSÂ®	NULL
,	NULL
apoptotic	NULL
cells	NULL
appear	NULL
as	NULL
a	NULL
sub	NULL
Figure	NULL
1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
Myc/Max	NULL
heterodimerization	NULL
domain	NULL
(	NULL
HLH-LZ	NULL
)	NULL
exchange	NULL
mutants	NULL
used	NULL
in	NULL
this	NULL
study	NULL
and	NULL
their	NULL
relationships	NULL
.	NULL

Myc	NULL
and	NULL
Max	NULL
form	NULL
transcriptionally	NULL
active	NULL
heterodimers	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
HLH-LZ	NULL
motifs	NULL
.	NULL

MycRX	NULL
(	NULL
21	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
reciprocally	NULL
exchanging	NULL
the	NULL
HLH-LZ	NULL
domain	NULL
of	NULL
wild-type	NULL
Myc	NULL
with	NULL
that	NULL
of	NULL
wild-type	NULL
Max	NULL
Strong	NULL
heterodimer	NULL
formation	NULL
,	NULL
binds	NULL
DNA	NULL
:	NULL
ACTIVE	NULL
Max	NULL
[	NULL
[	NULL
ef	NULL
nouiz	NULL
|	NULL
___//	NULL
)	NULL
DOMINANT	NULL
SUPPRESSOR	NULL
(	NULL
RX	NULL
for	NULL
reciprocal	NULL
exchange	NULL
,	NULL
Amati	NULL
et	NULL
'	NULL
--	NULL
Max	NULL
l	NULL
Hl	NULL
II	NULL
L7	NULL
H	NULL
]	NULL
Strong	NULL
heterodimer	NULL
formation	NULL
,	NULL
I	NULL
21	NULL
R	NULL
1	NULL
d	NULL
,	NULL
â	NULL
HM	NULL
â	NULL
:	NULL
J	NULL
binds	NULL
DNA	NULL
:	NULL
INACTIVE	NULL
al	NULL
.	NULL

[	NULL
21	NULL
]	NULL
)	NULL
.	NULL

MaxRX	NULL
(	NULL
21	NULL
)	NULL
was	NULL
engineere	NULL
Maxkx	NULL
[	NULL
[	NULL
ef	NULL
nouiz	NULL
|	NULL
___	NULL
}	NULL
/	NULL
)	NULL
(	NULL
titrates	NULL
out	NULL
Max	NULL
,	NULL
blocks	NULL
binding	NULL
of	NULL
by	NULL
exchanging	NULL
the	NULL
HLH-LZ	NULL
of	NULL
wild	NULL
myeC	NULL
)	NULL
/	NULL
--	NULL
-	NULL
poo	NULL
MyeRXC	NULL
)	NULL
ao	NULL
]	NULL
mex	NULL
C/-	NULL
fons	NULL
]	NULL
--	NULL
>	NULL
MyeRX	NULL
[	NULL
7	NULL
[	NULL
EJ	NULL
coz	NULL
]	NULL
Marx	NULL
|___//	NULL
2414	NULL
MaxRX	NULL
[	NULL
[	NULL
b	NULL
]	NULL
I	NULL
,	NULL
``	NULL
|	NULL
3M	NULL
active	NULL
dimers	NULL
to	NULL
DNA	NULL
)	NULL
type	NULL
Max	NULL
with	NULL
that	NULL
from	NULL
Myc	NULL
.	NULL

The	NULL
diagram	NULL
shows	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
two	NULL
exchange	NULL
mutants	NULL
,	NULL
together	NULL
with	NULL
mye	NULL
CJ	NULL
/-	NULL
--	NULL
-	NULL
{	NULL
Poole	NULL
tormcuon	NULL
,	NULL
_	NULL
their	NULL
interactions	NULL
with	NULL
the	NULL
wild-type	NULL
MyeRXL	NULL
;	NULL
/	NULL
[	NULL
ef	NULL
urz	NULL
]	NULL
_|	NULL
]	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
:	NULL
INACTIVE	NULL
proteins	NULL
.	NULL

MycRX	NULL
forms	NULL
dimers	NULL
with	NULL
(	NULL
titrates	NULL
out	NULL
Myc	NULL
)	NULL
both	NULL
MaxRX	NULL
and	NULL
with	NULL
wild-type	NULL
Myc	NULL
;	NULL
however	NULL
,	NULL
only	NULL
MycRX-MaxRX	NULL
dimers	NULL
can	NULL
bind	NULL
DNA	NULL
and	NULL
are	NULL
transcriptionally	NULL
active	NULL
.	NULL

MaxRX	NULL
can	NULL
form	NULL
dimers	NULL
with	NULL
MycRX	NULL
or	NULL
with	NULL
wild-type	NULL
Max	NULL
.	NULL

Either	NULL
dimer	NULL
may	NULL
bind	NULL
DNA	NULL
,	NULL
but	NULL
only	NULL
the	NULL
MycRX-MaxRX	NULL
dimer	NULL
is	NULL
active	NULL
.	NULL

COMPLEMENTATION	NULL
Strong	NULL
heterodimer	NULL
formation	NULL
,	NULL
bindS	NULL
DNA	NULL
:	NULL
ACTIVE	NULL
Functional	NULL
Myc-Max	NULL
Heterodimer	NULL
and	NULL
Apoptosis	NULL
in	NULL
T	NULL
Cell	NULL
Hybridomas	NULL
A	NULL
%	NULL
Apoptosis	NULL
112	NULL
0	NULL
20	NULL
4	NULL
__	NULL
P	NULL
All	NULL
1242	NULL
Al.1	NULL
Al.1.pBABE	NULL
A1l.1	NULL
pBabe	NULL
11.84	NULL
Al.1	NULL
.	NULL

maxRx	NULL
16.14	NULL
Al.l.maxRxmycRx	NULL
17.78	NULL
Pa	NULL
O	NULL
0	NULL
--	NULL
%	NULL
subdiploid	NULL
cells	NULL
+3	NULL
A	NULL
--	NULL
%	NULL
dead	NULL
cells	NULL
(	NULL
triplicates	NULL
,	NULL
PI	NULL
uptake	NULL
)	NULL
5	NULL
a	NULL
--	NULL
mean	NULL
%	NULL
apoptotic	NULL
cells	NULL
(	NULL
with	NULL
std	NULL
.	NULL

=	NULL
jâl	NULL
dev	NULL
)	NULL
-	NULL
=-	NULL
3	NULL
|	NULL
Al..	NULL
A11	NULL
.	NULL

mycRXmaxRX	NULL
Figure	NULL
2	NULL
.	NULL

Inhibition	NULL
of	NULL
activation-induced	NULL
cell	NULL
death	NULL
by	NULL
the	NULL
stable	NULL
expression	NULL
of	NULL
MaxRX	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
monoclonal	NULL
antibody	NULL
(	NULL
2	NULL
)	NULL
measured	NULL
by	NULL
PI	NULL
staining	NULL
of	NULL
unfixed	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
by	NULL
fixation	NULL
and	NULL
staining	NULL
with	NULL
PI	NULL
for	NULL
assessment	NULL
of	NULL
DNA	NULL
content	NULL
(	NULL
O	NULL
{	NULL
]	NULL
)	NULL
.	NULL

Included	NULL
is	NULL
a	NULL
determination	NULL
of	NULL
IL-2	NULL
produced	NULL
after	NULL
stimulation	NULL
in	NULL
one	NULL
of	NULL
the	NULL
experiments	NULL
(	NULL
O	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Determination	NULL
of	NULL
DNA	NULL
fragmentation	NULL
by	NULL
FACSÂ®	NULL
analysis	NULL
of	NULL
cells	NULL
labeled	NULL
in	NULL
situ	NULL
with	NULL
terminal	NULL
deoxytransferase	NULL
and	NULL
UTP-biotin/avidin	NULL
FITC	NULL
after	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
.	NULL

A1.1	NULL
maxRX	NULL
transfectants	NULL
were	NULL
induced	NULL
to	NULL
undergo	NULL
apoptosis	NULL
by	NULL
overnight	NULL
culture	NULL
in	NULL
anti-CD3	NULL
coated	NULL
plates	NULL
.	NULL

Data	NULL
shown	NULL
for	NULL
cell	NULL
death	NULL
as	NULL
determined	NULL
by	NULL
direct	NULL
staining	NULL
of	NULL
unfixed	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
with	NULL
PI	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
with	NULL
standard	NULL
deviation	NULL
.	NULL

Bars	NULL
represent	NULL
the	NULL
mean	NULL
apoptosis	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
with	NULL
standard	NULL
deviation	NULL
.	NULL

diploid	NULL
population	NULL
,	NULL
owing	NULL
to	NULL
the	NULL
fragmentation	NULL
and	NULL
subsequent	NULL
loss	NULL
of	NULL
the	NULL
soluble	NULL
DNA	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
cells	NULL
were	NULL
analyzed	NULL
using	NULL
an	NULL
in	NULL
situ	NULL
terminal	NULL
deoxytransferase	NULL
reaction	NULL
to	NULL
label	NULL
3'-OH	NULL
ends	NULL
in	NULL
the	NULL
DNA	NULL
,	NULL
a	NULL
method	NULL
that	NULL
detects	NULL
apoptosis	NULL
involving	NULL
DNA	NULL
fragmentation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
a	NULL
pronounced	NULL
apoptotic	NULL
peak	NULL
was	NULL
observed	NULL
after	NULL
activation	NULL
of	NULL
control	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
cells	NULL
expressing	NULL
MaxRX	NULL
.	NULL

This	NULL
effect	NULL
of	NULL
MaxRX	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MycRX	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
using	NULL
c-myc	NULL
antisense	NULL
oligodeoxynucleotides	NULL
indicated	NULL
that	NULL
inhibition	NULL
of	NULL
Myc	NULL
expression	NULL
in	NULL
T	NULL
hybridoma	NULL
cells	NULL
prevented	NULL
activation-induced	NULL
apoptosis	NULL
but	NULL
not	NULL
activation-induced	NULL
cytokine	NULL
production	NULL
(	NULL
5	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
cytokine	NULL
production	NULL
in	NULL
the	NULL
cells	NULL
expressing	NULL
MaxRX	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
cells	NULL
expressing	NULL
MaxRX	NULL
produced	NULL
a	NULL
level	NULL
of	NULL
cytokine	NULL
after	NULL
activation	NULL
that	NULL
was	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
the	NULL
other	NULL
cells	NULL
,	NULL
despite	NULL
significantly	NULL
less	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
Myc-Max	NULL
heterodimer	NULL
appears	NULL
not	NULL
to	NULL
be	NULL
important	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
after	NULL
activation	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
5	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
2,300	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
start	NULL
codon	NULL
indicates	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
CACGTG	NULL
consensus	NULL
Myc-Max	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
use	NULL
of	NULL
cloned	NULL
cell	NULL
lines	NULL
generated	NULL
after	NULL
transfection	NULL
and	NULL
selection	NULL
carries	NULL
the	NULL
potential	NULL
problem	NULL
that	NULL
any	NULL
clone	NULL
might	NULL
gain	NULL
or	NULL
lose	NULL
a	NULL
function	NULL
due	NULL
to	NULL
random	NULL
factors	NULL
not	NULL
related	NULL
to	NULL
the	NULL
transfected	NULL
gene	NULL
.	NULL

An	NULL
alternative	NULL
approach	NULL
is	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
bulk	NULL
.	NULL

Thus	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
selected	NULL
,	NULL
and	NULL
their	NULL
response	NULL
to	NULL
activation	NULL
was	NULL
examined	NULL
without	NULL
cloning	NULL
.	NULL

Results	NULL
from	NULL
several	NULL
bulk	NULL
transfections	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Again	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
2415	NULL
Bissonnette	NULL
et	NULL
al	NULL
.	NULL

Log	NULL
Fluorescence	NULL
(	NULL
FITC	NULL
)	NULL
expression	NULL
of	NULL
MaxRX	NULL
inhibited	NULL
activation-induced	NULL
apoptosis	NULL
while	NULL
coexpression	NULL
of	NULL
both	NULL
MaxRX	NULL
and	NULL
MycRX	NULL
did	NULL
not	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
MycRX	NULL
were	NULL
inconsistent	NULL
,	NULL
but	NULL
generally	NULL
this	NULL
molecule	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
significantly	NULL
inhibit	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

In	NULL
one	NULL
experiment	NULL
we	NULL
examined	NULL
IL-2	NULL
produc-tion	NULL
,	NULL
and	NULL
found	NULL
equivalent	NULL
levels	NULL
of	NULL
cytokine	NULL
produced	NULL
by	NULL
cells	NULL
expressing	NULL
MaxRX	NULL
,	NULL
MycRX-MaxRX	NULL
,	NULL
and	NULL
the	NULL
control	NULL
vectors	NULL
,	NULL
as	NULL
above	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
those	NULL
obtained	NULL
using	NULL
cloned	NULL
cells	NULL
above	NULL
,	NULL
and	NULL
together	NULL
,	NULL
these	NULL
demonstrate	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
Myc	NULL
,	NULL
the	NULL
function	NULL
of	NULL
Max	NULL
is	NULL
required	NULL
for	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
MycRX	NULL
to	NULL
block	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
MaxRX	NULL
strongly	NULL
suggests	NULL
that	NULL
Myc	NULL
and	NULL
Max	NULL
function	NULL
as	NULL
a	NULL
heterodimer	NULL
in	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
we	NULL
also	NULL
examined	NULL
possible	NULL
effects	NULL
of	NULL
wild-type	NULL
Max	NULL
on	NULL
activation-induced	NULL
apoptosis	NULL
in	NULL
bulk	NULL
transfected	NULL
T	NULL
hybridoma	NULL
cells	NULL
.	NULL

Max	NULL
is	NULL
known	NULL
to	NULL
form	NULL
homodimers	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
27	NULL
,	NULL
28	NULL
)	NULL
and	NULL
can	NULL
inhibit	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
Myc-Max	NULL
heterodimer	NULL
in	NULL
vivo	NULL
(	NULL
17	NULL
,	NULL
20	NULL
,	NULL
21	NULL
,	NULL
29-31	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
wild-type	NULL
Max	NULL
similarly	NULL
inhibited	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
susceptibility	NULL
to	NULL
activation-induced	NULL
apoptosis	NULL
can	NULL
apparently	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
levels	NULL
of	NULL
Max	NULL
in	NULL
the	NULL
cell	NULL
,	NULL
and	NULL
this	NULL
might	NULL
therefore	NULL
represent	NULL
a	NULL
potential	NULL
control	NULL
mechanism	NULL
.	NULL

Similarly	NULL
,	NULL
other	NULL
proteins	NULL
that	NULL
influence	NULL
the	NULL
availability	NULL
of	NULL
Max	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Mad	NULL
[	NULL
32	NULL
]	NULL
)	NULL
might	NULL
have	NULL
roles	NULL
in	NULL
regulating	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
Myc	NULL
expression	NULL
can	NULL
trigger	NULL
apoptosis	NULL
(	NULL
6-9	NULL
)	NULL
which	NULL
is	NULL
inhibited	NULL
by	NULL
growth	NULL
factors	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
or	NULL
by	NULL
the	NULL
Bcl-2	NULL
protein	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
studies	NULL
have	NULL
involved	NULL
the	NULL
use	NULL
of	NULL
transfected	NULL
cell	NULL
lines	NULL
.	NULL

Recently	NULL
,	NULL
these	NULL
observations	NULL
were	NULL
extended	NULL
to	NULL
group	NULL
I	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
which	NULL
dis	NULL
Brief	NULL
Definitive	NULL
Report	NULL
%	NULL
Apoptosis	NULL
0	NULL
20	NULL
40	NULL
60	NULL
All	NULL
Al.1.pDor	NULL
Al.1.pBabe	NULL
Al.l.max	NULL
Al.l.maxRX	NULL
Al.l.mycRX	NULL
A1.1.mycRXmaxRX	NULL
A	NULL
HA	NULL
A	NULL
0	NULL
-	NULL
@	NULL
-	NULL
--	NULL
%	NULL
apoptotic	NULL
cells	NULL
(	NULL
triplicates	NULL
,	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
)	NULL
--	NULL
%	NULL
subdiploid	NULL
cells	NULL
--	NULL
mean	NULL
%	NULL
apoptotic	NULL
cells	NULL
(	NULL
with	NULL
std	NULL
.	NULL

dev	NULL
.	NULL
)	NULL

play	NULL
a	NULL
high	NULL
incidence	NULL
of	NULL
apoptosis	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Inhibition	NULL
of	NULL
c-Myc	NULL
expression	NULL
by	NULL
IFN-	NULL
or	NULL
c-myc	NULL
antisense	NULL
oligodeoxynucleotides	NULL
protected	NULL
these	NULL
cells	NULL
from	NULL
apoptosis	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
c-Myc	NULL
plays	NULL
roles	NULL
in	NULL
apoptosis	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
conditions	NULL
.	NULL

Amati	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
Myc-induced	NULL
apoptosis	NULL
in	NULL
fibroblasts	NULL
depends	NULL
upon	NULL
the	NULL
interaction	NULL
of	NULL
Myc	NULL
and	NULL
Max	NULL
.	NULL

They	NULL
used	NULL
constructs	NULL
encoding	NULL
mutant	NULL
proteins	NULL
in	NULL
which	NULL
the	NULL
residues	NULL
forming	NULL
electrostatic	NULL
interactions	NULL
within	NULL
the	NULL
leucine	NULL
zipper	NULL
heterodimerization	NULL
motif	NULL
were	NULL
reciprocally	NULL
exchanged	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
resulting	NULL
MycEG	NULL
protein	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
Max	NULL
,	NULL
but	NULL
does	NULL
bind	NULL
to	NULL
a	NULL
reciprocally	NULL
modified	NULL
MaxEG	NULL
protein	NULL
.	NULL

When	NULL
both	NULL
are	NULL
introduced	NULL
into	NULL
fibroblasts	NULL
,	NULL
the	NULL
cells	NULL
became	NULL
highly	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
Myc	NULL
induces	NULL
apoptosis	NULL
via	NULL
interaction	NULL
with	NULL
Max	NULL
.	NULL

Our	NULL
observations	NULL
on	NULL
activation-induced	NULL
apoptosis	NULL
are	NULL
completely	NULL
consistent	NULL
with	NULL
these	NULL
findings	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
systems	NULL
described	NULL
here	NULL
,	NULL
apoptosis	NULL
may	NULL
occur	NULL
due	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
Myc	NULL
expression	NULL
in	NULL
some	NULL
cases	NULL
.	NULL

Thulasi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
noted	NULL
that	NULL
glucocorticoids	NULL
inhibit	NULL
Myc	NULL
expression	NULL
in	NULL
cells	NULL
in	NULL
which	NULL
they	NULL
induce	NULL
apoptosis	NULL
,	NULL
and	NULL
constitutive	NULL
expression	NULL
of	NULL
Myc	NULL
appears	NULL
to	NULL
protect	NULL
these	NULL
cells	NULL
.	NULL

Further	NULL
,	NULL
in	NULL
a	NULL
system	NULL
partially	NULL
related	NULL
to	NULL
the	NULL
one	NULL
described	NULL
here	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
WEHI-231	NULL
B	NULL
cell	NULL
line	NULL
via	NULL
ligation	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
induces	NULL
apoptosis	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
Myc	NULL
ex	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
activation-induced	NULL
apoptosis	NULL
in	NULL
bulk	NULL
(	NULL
un-cloned	NULL
)	NULL
transfected	NULL
cells	NULL
expressing	NULL
Myc	NULL
and	NULL
Max	NULL
exchange	NULL
mutants	NULL
.	NULL

Percent	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
after	NULL
stimulation	NULL
with	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
as	NULL
determined	NULL
by	NULL
FACSÂ®	NULL
analysis	NULL
of	NULL
DNA	NULL
content	NULL
in	NULL
cells	NULL
fixed	NULL
and	NULL
stained	NULL
with	NULL
PI	NULL
(	NULL
OAQ	NULL
)	NULL
,	NULL
or	NULL
by	NULL
assessment	NULL
of	NULL
morphology	NULL
and	NULL
viability	NULL
of	NULL
cells	NULL
in	NULL
triplicate	NULL
cultures	NULL
stained	NULL
with	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
,	NULL
with	NULL
standard	NULL
deviation	NULL
(	NULL
@	NULL
)	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Bars	NULL
represent	NULL
the	NULL
mean	NULL
apoptosis	NULL
of	NULL
four	NULL
experiments	NULL
,	NULL
with	NULL
standard	NULL
deviation	NULL
.	NULL

The	NULL
induction	NULL
and	NULL
assessment	NULL
of	NULL
apoptosis	NULL
by	NULL
DNA	NULL
content	NULL
was	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
.	NULL

For	NULL
the	NULL
quantitation	NULL
of	NULL
apoptosis	NULL
by	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
from	NULL
cultures	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
immediately	NULL
stained	NULL
and	NULL
scored	NULL
by	NULL
UV	NULL
light	NULL
microscopy	NULL
.	NULL

Data	NULL
shown	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
cultures	NULL
with	NULL
standard	NULL
deviation	NULL
.	NULL

pression	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
c-myc-antisense	NULL
oligonucleotides	NULL
were	NULL
observed	NULL
to	NULL
stabilize	NULL
expression	NULL
of	NULL
Myc	NULL
in	NULL
the	NULL
activated	NULL
B	NULL
lymphomas	NULL
and	NULL
thereby	NULL
prevent	NULL
apoptosis	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
contrasting	NULL
role	NULL
for	NULL
Myc	NULL
as	NULL
an	NULL
apparent	NULL
survival	NULL
signal	NULL
in	NULL
the	NULL
transformed	NULL
B	NULL
cells	NULL
,	NULL
lines	NULL
that	NULL
resist	NULL
activation-induced	NULL
apoptosis	NULL
fail	NULL
to	NULL
downregulate	NULL
Myc	NULL
upon	NULL
activation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Myc	NULL
appears	NULL
to	NULL
have	NULL
strikingly	NULL
different	NULL
roles	NULL
in	NULL
the	NULL
induction	NULL
versus	NULL
prevention	NULL
of	NULL
apoptosis	NULL
in	NULL
different	NULL
systems	NULL
.	NULL

The	NULL
Myc-Max	NULL
heterodimer	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
regulator	NULL
to	NULL
induce	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
and	NULL
those	NULL
of	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
in	NULL
which	NULL
Myc-Max	NULL
promotes	NULL
apoptosis	NULL
therefore	NULL
suggest	NULL
that	NULL
further	NULL
transcription	NULL
is	NULL
required	NULL
for	NULL
cell	NULL
death	NULL
,	NULL
and	NULL
thus	NULL
Myc-Max-induced	NULL
genes	NULL
should	NULL
be	NULL
examined	NULL
for	NULL
their	NULL
potential	NULL
roles	NULL
in	NULL
inducing	NULL
apoptosis	NULL
.	NULL

One	NULL
gene	NULL
that	NULL
is	NULL
known	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
Myc	NULL
is	NULL
ornithine	NULL
decar-boxylase	NULL
(	NULL
ODC	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Packham	NULL
and	NULL
Cleveland	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
ODC	NULL
in	NULL
32D	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
c-Myc	NULL
expression	NULL
promotes	NULL
IL-3	NULL
withdrawal-induced	NULL
apoptosis	NULL
.	NULL

They	NULL
found	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
ODC	NULL
gene	NULL
from	NULL
a	NULL
constitutive	NULL
promoter	NULL
rendered	NULL
32D	NULL
cells	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
Myc	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
they	NULL
found	NULL
that	NULL
phar-macologic	NULL
inhibition	NULL
of	NULL
ODC	NULL
activity	NULL
in	NULL
Myc-expressing	NULL
cells	NULL
reduced	NULL
their	NULL
susceptibility	NULL
to	NULL
apoptosis	NULL
induction	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
one	NULL
Myc-induced	NULL
gene	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
one	NULL
form	NULL
of	NULL
apoptosis	NULL
.	NULL

The	NULL
authors	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Dr.	NULL
Bruno	NULL
Amati	NULL
for	NULL
providing	NULL
valuable	NULL
reagents	NULL
and	NULL
Dr.	NULL
Don	NULL
New	NULL
meyer	NULL
for	NULL
valuable	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
GM-52735	NULL
)	NULL
and	NULL
by	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
(	NULL
CB-82	NULL
)	NULL
.	NULL

2416	NULL
Functional	NULL
Myc-Max	NULL
Heterodimer	NULL
and	NULL
Apoptosis	NULL
in	NULL
T	NULL
Cell	NULL
Hybridomas	NULL
Address	NULL
correspondence	NULL
to	NULL
Reid	NULL
P.	NULL
Bissonnette	NULL
,	NULL
Ligand	NULL
Pharmaceuticals	NULL
,	NULL
9393	NULL
Towne	NULL
Center	NULL
Drive	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92121	NULL
,	NULL
which	NULL
is	NULL
his	NULL
current	NULL
address	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
22	NULL
June	NULL
1994	NULL
.	NULL

References	NULL
1	NULL
.	NULL

5	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

Cohen	NULL
,	NULL
J.J.	NULL
,	NULL
and	NULL
R.C	NULL
.	NULL

Duke	NULL
.	NULL

1984	NULL
.	NULL

Glucocorticoid	NULL
activation	NULL
of	NULL
a	NULL
calcium-dependent	NULL
endonuclease	NULL
in	NULL
thymocyte	NULL
nuclei	NULL
leads	NULL
to	NULL
cell	NULL
death	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

132:38.	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
M.G	NULL
.	NULL

Szalay	NULL
,	NULL
L.	NULL
Paskar	NULL
,	NULL
M.	NULL
Boyer	NULL
,	NULL
B.	NULL
Singh	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Green	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
induced	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cell	NULL
hybridomas	NULL
is	NULL
due	NULL
to	NULL
apoptosis	NULL
:	NULL
morphological	NULL
aspects	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3326.	NULL
.	NULL

Odaka	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Kizaki	NULL
,	NULL
and	NULL
T.	NULL
Tadakuma	NULL
.	NULL

1990	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
mediated	NULL
DNA	NULL
fragmentation	NULL
and	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cell	NULL
hybridomas	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:2096.	NULL
.	NULL

Ucket	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
J.D	NULL
.	NULL

Ashwell	NULL
,	NULL
and	NULL
G.	NULL
Nickas	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
driven	NULL
T	NULL
cell	NULL
death	NULL
.	NULL

I	NULL
.	NULL

Requirements	NULL
for	NULL
de	NULL
novo	NULL
transcription	NULL
and	NULL
translation	NULL
and	NULL
association	NULL
with	NULL
genome	NULL
fragmentation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3461	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
J.M	NULL
.	NULL

Glynn	NULL
,	NULL
LJ	NULL
.	NULL

Guilbert	NULL
,	NULL
T.G	NULL
.	NULL

Cotter	NULL
,	NULL
R.P	NULL
.	NULL

Bissonnette	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Green	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
for	NULL
c-myc	NULL
in	NULL
activation-induced	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cell	NULL
hybridomas	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

257:212.	NULL
.	NULL

Wyllie	NULL
,	NULL
A.H.	NULL
,	NULL
K.A	NULL
.	NULL

Rose	NULL
,	NULL
R.G	NULL
.	NULL

Morris	NULL
,	NULL
C.M	NULL
.	NULL

Steel	NULL
,	NULL
E.	NULL
For	NULL
ster	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Spandidos	NULL
.	NULL

1987	NULL
.	NULL

Rodent	NULL
fibroblast	NULL
tumors	NULL
expressing	NULL
human	NULL
myc	NULL
and	NULL
ras	NULL
genes	NULL
:	NULL
growth	NULL
,	NULL
metastasis	NULL
and	NULL
endogenous	NULL
oncogene	NULL
expression	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
56:251.	NULL
.	NULL

Askew	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
R.A.	NULL
Ashmun	NULL
,	NULL
B.C	NULL
.	NULL

Simmons	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Cleve-	NULL
land	NULL
.	NULL

1991	NULL
.	NULL

Constitutive	NULL
c-myc	NULL
expression	NULL
in	NULL
an	NULL
II	NULL
>	NULL
3-dependent	NULL
myeloid	NULL
cell	NULL
line	NULL
suppresses	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
accelerates	NULL
apoptosis	NULL
.	NULL

Oncogene	NULL
.	NULL

6:1915.	NULL
.	NULL

Evan	NULL
,	NULL
G.I	NULL
.	NULL

,	NULL
A.H.	NULL
Wyllie	NULL
,	NULL
C.S	NULL
.	NULL

Gilbert	NULL
,	NULL
TD	NULL
.	NULL

Littlewood	NULL
,	NULL
H.	NULL
Land	NULL
,	NULL
M.	NULL
Brooks	NULL
,	NULL
C.M	NULL
.	NULL

Waters	NULL
,	NULL
L.Z	NULL
.	NULL

Penn	NULL
,	NULL
and	NULL
D.C.	NULL
Han-cock	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
fibroblasts	NULL
by	NULL
c-myc	NULL
protein	NULL
.	NULL

Cell	NULL
.	NULL

69:119.	NULL
.	NULL

Bissonnette	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
Y.	NULL
Shi	NULL
,	NULL
A.	NULL
Mahboubi	NULL
,	NULL
J.M	NULL
.	NULL

Glynn	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Green	NULL
.	NULL

1994	NULL
.	NULL

C-myc	NULL
and	NULL
apoptosis	NULL
.	NULL

In	NULL
Apoptosis	NULL
II	NULL
:	NULL
The	NULL
Molecular	NULL
Basis	NULL
of	NULL
Cell	NULL
Death	NULL
.	NULL

L.D	NULL
.	NULL

Tomei	NULL
and	NULL
FO	NULL
.	NULL

Cope	NULL
,	NULL
editors	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

327-356	NULL
.	NULL

Bissonnette	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
F.	NULL
Echeverri	NULL
,	NULL
A.	NULL
Mahboubi	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Green	NULL
.	NULL

1992	NULL
.	NULL

Apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
c-myc	NULL
is	NULL
inhibited	NULL
by	NULL
bel-2	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

359:552	NULL
.	NULL

Fanidi	NULL
,	NULL
A.	NULL
,	NULL
E.A	NULL
.	NULL

Harrington	NULL
,	NULL
and	NULL
G.I	NULL
.	NULL

Evan	NULL
.	NULL

1992	NULL
.	NULL

Cooperative	NULL
interaction	NULL
between	NULL
c-myc	NULL
and	NULL
bel-2	NULL
proto-oncogenes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

359:554	NULL
.	NULL

Wagner	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
M.B	NULL
.	NULL

Small	NULL
,	NULL
and	NULL
N.	NULL
Hay	NULL
.	NULL

1993	NULL
.	NULL

Mye-mediated	NULL
apoptosis	NULL
is	NULL
blocked	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
Bcl-2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2432	NULL
.	NULL

Rustgi	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
N.	NULL
Dyson	NULL
,	NULL
and	NULL
R.	NULL
Bernards	NULL
.	NULL

1991	NULL
.	NULL

Amino-terminal	NULL
domains	NULL
of	NULL
c-myc	NULL
and	NULL
N-myc	NULL
proteins	NULL
mediate	NULL
binding	NULL
to	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352:541	NULL
.	NULL

Roy	NULL
,	NULL
A.L	NULL
.	NULL

,	NULL
C.	NULL
Carruthers	NULL
,	NULL
T.	NULL
Gutjaht	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
.	NULL

1993	NULL
.	NULL

Direct	NULL
role	NULL
for	NULL
myc	NULL
in	NULL
transcription	NULL
initiation	NULL
mediated	NULL
by	NULL
interactions	NULL
with	NULL
TFII-I	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

35:359	NULL
.	NULL

Blackwood	NULL
,	NULL
E.M.	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Eisenman	NULL
.	NULL

1991	NULL
.	NULL

Max	NULL
:	NULL
a	NULL
helix-loop-helix	NULL
zipper	NULL
protein	NULL
that	NULL
forms	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
complex	NULL
with	NULL
Myc	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

2511211	NULL
.	NULL

Blackwood	NULL
,	NULL
E.M.	NULL
,	NULL
B.	NULL
Luscher	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Eisenman	NULL
.	NULL

1992	NULL
.	NULL

Myc	NULL
and	NULL
Max	NULL
associate	NULL
in	NULL
vivo	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

6:71	NULL
.	NULL

2417	NULL
Bissonnette	NULL
et	NULL
al	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

Amati	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
Dalton	NULL
,	NULL
MW	NULL
.	NULL

Brooks	NULL
,	NULL
TD	NULL
.	NULL

Littlewood	NULL
,	NULL
G.I	NULL
.	NULL

Evan	NULL
,	NULL
and	NULL
H.	NULL
Land	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
the	NULL
human	NULL
c-Myc	NULL
oncoprotein	NULL
in	NULL
yeast	NULL
requires	NULL
interaction	NULL
with	NULL
Max	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

359:423	NULL
.	NULL

Littlewood	NULL
,	NULL
T.D	NULL
.	NULL

,	NULL
B.	NULL
Amati	NULL
,	NULL
H.	NULL
Land	NULL
,	NULL
and	NULL
G.I	NULL
.	NULL

Evan	NULL
.	NULL

1992	NULL
.	NULL

Max	NULL
and	NULL
c-Myc/Max	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
cell	NULL
extracts	NULL
.	NULL

Oncogene	NULL
.	NULL

7:1783	NULL
.	NULL

Fisher	NULL
,	NULL
F.	NULL
,	NULL
D.H.	NULL
Crouch	NULL
,	NULL
P.-S.	NULL
Jayaraman	NULL
,	NULL
W.	NULL
Clark	NULL
,	NULL
D.A.F	NULL
.	NULL

Gillespie	NULL
,	NULL
and	NULL
C.R	NULL
.	NULL

Gooding	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
activation	NULL
by	NULL
Myc	NULL
and	NULL
Max	NULL
:	NULL
flanking	NULL
sequences	NULL
target	NULL
activation	NULL
to	NULL
a	NULL
subset	NULL
of	NULL
CACGTG	NULL
motifs	NULL
in	NULL
vivo	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:5075	NULL
.	NULL

Amin	NULL
,	NULL
C.	NULL
,	NULL
A.J	NULL
.	NULL

Wagner	NULL
,	NULL
and	NULL
N.	NULL
Hay	NULL
.	NULL

1993	NULL
.	NULL

Sequence-specific	NULL
transcriptional	NULL
activation	NULL
by	NULL
Myc	NULL
and	NULL
repression	NULL
by	NULL
Max	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:383	NULL
.	NULL

Amati	NULL
,	NULL
B.	NULL
,	NULL
M.W	NULL
.	NULL

Brooks	NULL
,	NULL
N.	NULL
Levy	NULL
,	NULL
T.D	NULL
.	NULL

Littlewood	NULL
,	NULL
G.I	NULL
.	NULL

Evan	NULL
,	NULL
and	NULL
H.	NULL
Land	NULL
.	NULL

1993	NULL
.	NULL

Oncogenic	NULL
activity	NULL
of	NULL
the	NULL
c-Myc	NULL
protein	NULL
requires	NULL
dimerization	NULL
with	NULL
Max	NULL
.	NULL

Cell	NULL
.	NULL

72:233	NULL
.	NULL

Leo	NULL
,	NULL
O.	NULL
,	NULL
M.	NULL
Foo	NULL
,	NULL
D.H.	NULL
Sachs	NULL
,	NULL
L.E	NULL
.	NULL

Samelson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Blue-stone	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
a	NULL
murine	NULL
T3	NULL
polypeptide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

84:1374	NULL
.	NULL

Gorezyca	NULL
,	NULL
W.	NULL
,	NULL
S.	NULL
Bruno	NULL
,	NULL
R.J.	NULL
Darzynkiewicz	NULL
,	NULL
J.	NULL
Gong	NULL
,	NULL
and	NULL
Z.	NULL
Darzynkiewicz	NULL
.	NULL

1992	NULL
.	NULL

DNA	NULL
strand	NULL
breaks	NULL
during	NULL
apoptosis	NULL
:	NULL
their	NULL
early	NULL
in	NULL
situ	NULL
detection	NULL
by	NULL
the	NULL
terminal	NULL
deox-ynucleotidy	NULL
]	NULL
l	NULL
transferase	NULL
and	NULL
nick	NULL
translation	NULL
assays	NULL
and	NULL
prevention	NULL
by	NULL
serine	NULL
protease	NULL
inhibitors	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Oncol	NULL
.	NULL

1:639	NULL
.	NULL

Gillis	NULL
,	NULL
S.	NULL
,	NULL
M.M	NULL
.	NULL

Ferm	NULL
,	NULL
W.	NULL
Ou	NULL
,	NULL
and	NULL
K.A	NULL
.	NULL

Smith	NULL
.	NULL

1978	NULL
.	NULL

T	NULL
cell	NULL
growth	NULL
factor	NULL
:	NULL
parameters	NULL
of	NULL
production	NULL
and	NULL
a	NULL
quantitative	NULL
microassay	NULL
for	NULL
activity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

120:2027	NULL
.	NULL

DelBino	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Lassota	NULL
,	NULL
and	NULL
Z.	NULL
Darzynkiewicz	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
S-phase	NULL
cytotoxicity	NULL
of	NULL
camptothecin	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
.	NULL

193:27	NULL
.	NULL

Darzynkiewicz	NULL
,	NULL
Z.	NULL
,	NULL
S.	NULL
Bruno	NULL
,	NULL
G.	NULL
DelBino	NULL
,	NULL
W.	NULL
Gorezyca	NULL
,	NULL
M.A	NULL
.	NULL

Hotz	NULL
,	NULL
P.	NULL
Lassota	NULL
,	NULL
and	NULL
F.	NULL
Traganos	NULL
.	NULL

1992	NULL
.	NULL

Features	NULL
of	NULL
apoptotic	NULL
cells	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cytometry	NULL
.	NULL

13:795	NULL
.	NULL

Berberich	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.D	NULL
.	NULL

Cole	NULL
.	NULL

1992	NULL
.	NULL

Casein	NULL
kinase	NULL
II	NULL
inhibits	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
Max	NULL
homodimers	NULL
but	NULL
not	NULL
Myc/Max	NULL
heterodimers	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

6:166	NULL
.	NULL

Kato	NULL
,	NULL
G.J	NULL
.	NULL

,	NULL
W.M.F	NULL
.	NULL

Lee	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
and	NULL
CV	NULL
.	NULL

Dang	NULL
.	NULL

1992	NULL
.	NULL

Max	NULL
:	NULL
functional	NULL
domains	NULL
and	NULL
interaction	NULL
with	NULL
c-Myc	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

6:81-92	NULL
.	NULL

Kretzner	NULL
,	NULL
L.	NULL
,	NULL
EM	NULL
.	NULL

Blackwood	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Eisenman	NULL
.	NULL

1992	NULL
.	NULL

Myc	NULL
and	NULL
Max	NULL
proteins	NULL
possess	NULL
distinct	NULL
transcriptional	NULL
activi-ties	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

359:426	NULL
.	NULL

Makela	NULL
,	NULL
TP	NULL
.	NULL

,	NULL
PJ	NULL
.	NULL

Koskinen	NULL
,	NULL
L.	NULL
Vastrik	NULL
,	NULL
and	NULL
K.	NULL
Alitalo	NULL
.	NULL

1992	NULL
.	NULL

Alternative	NULL
forms	NULL
of	NULL
Max	NULL
as	NULL
enhancers	NULL
or	NULL
suppressors	NULL
of	NULL
Myc-Ras	NULL
cotransformation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

256:373	NULL
.	NULL

Mukherjee	NULL
,	NULL
B.	NULL
,	NULL
SD	NULL
.	NULL

Morgenbesse	NULL
,	NULL
and	NULL
R.A.	NULL
DePinho	NULL
.	NULL

1992	NULL
.	NULL

Myc	NULL
family	NULL
oncoproteins	NULL
function	NULL
through	NULL
a	NULL
common	NULL
pathway	NULL
to	NULL
transform	NULL
normal	NULL
cells	NULL
in	NULL
culture	NULL
:	NULL
cross-interference	NULL
by	NULL
Max	NULL
and	NULL
trans-acting	NULL
dominant	NULL
mutants	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

6:1480	NULL
.	NULL

Ayer	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
L.	NULL
Kretzner	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Eisenman	NULL
.	NULL

1993	NULL
.	NULL

Mad	NULL
:	NULL
a	NULL
heterodimeric	NULL
partner	NULL
for	NULL
Max	NULL
that	NULL
antagonizes	NULL
Myc	NULL
transcriptional	NULL
activity	NULL
.	NULL

Cell	NULL
.	NULL

72:211	NULL
.	NULL

Milner	NULL
,	NULL
A.E	NULL
,	NULL
,	NULL
R.J.	NULL
Grand	NULL
,	NULL
C.M	NULL
.	NULL

Waters	NULL
,	NULL
and	NULL
C.D	NULL
.	NULL

Gregory	NULL
.	NULL

Brief	NULL
Definitive	NULL
Report	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

1993	NULL
.	NULL

Apoptosis	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
is	NULL
driven	NULL
by	NULL
c-myc	NULL
.	NULL

Oncogene	NULL
.	NULL

8:3385	NULL
.	NULL

Amati	NULL
,	NULL
B.	NULL
,	NULL
T.D	NULL
.	NULL

Littlewood	NULL
,	NULL
G.I	NULL
.	NULL

Evan	NULL
,	NULL
and	NULL
H.	NULL
Land	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
c-Myc	NULL
protein	NULL
induces	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
apoptosis	NULL
through	NULL
dimerization	NULL
with	NULL
Max	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:5083	NULL
.	NULL

Thulasi	NULL
,	NULL
R.	NULL
,	NULL
DV	NULL
.	NULL

Harbour	NULL
,	NULL
and	NULL
E.B	NULL
.	NULL

Thompson	NULL
.	NULL

1993	NULL
.	NULL

Suppression	NULL
of	NULL
c-myc	NULL
is	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
glucocorticoid-induced	NULL
human	NULL
leukemic	NULL
cell	NULL
lysis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:18306	NULL
.	NULL

Fischer	NULL
,	NULL
G.	NULL
,	NULL
SC	NULL
.	NULL

Kent	NULL
,	NULL
L.	NULL
Joseph	NULL
,	NULL
D.R	NULL
.	NULL

Green	NULL
,	NULL
and	NULL
D.W.	NULL
Scott	NULL
.	NULL

1994	NULL
.	NULL

Lymphoma	NULL
models	NULL
for	NULL
B	NULL
cell	NULL
activation	NULL
and	NULL
tolerance	NULL
.	NULL

X.	NULL
Anti-u-mediated	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cell	NULL
lymphomas	NULL
is	NULL
prevented	NULL
by	NULL
the	NULL
stabilization	NULL
of	NULL
myc	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
,	NULL
179:221	NULL
.	NULL

2418	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

Hibner	NULL
,	NULL
U.	NULL
,	NULL
L.E	NULL
.	NULL

Benhamou	NULL
,	NULL
M.	NULL
Haury	NULL
,	NULL
P.-A	NULL
.	NULL

Cazenave	NULL
,	NULL
and	NULL
P.	NULL
Sarthou	NULL
.	NULL

1993	NULL
.	NULL

Signaling	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
induction	NULL
in	NULL
WEHI-231	NULL
B	NULL
lymphoma	NULL
cells	NULL
.	NULL

Eur	NULL
J.	NULL
Immunol	NULL
.	NULL

23:2821	NULL
.	NULL

Wagner	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
C.	NULL
Meyers	NULL
,	NULL
L.A.	NULL
Laimins	NULL
,	NULL
and	NULL
N.	NULL
Hay	NULL
.	NULL

1994.	NULL
c-Myc	NULL
induces	NULL
the	NULL
expression	NULL
and	NULL
activity	NULL
of	NULL
ornithine	NULL
decar-boxylase	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
11:879	NULL
.	NULL

Packham	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Cleveland	NULL
.	NULL

1994	NULL
.	NULL

Ornithine	NULL
decarbox-ylase	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
c-Myc	NULL
induced	NULL
apoptosis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5741.	NULL
.	NULL

Mishell	NULL
,	NULL
B.B	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1980	NULL
.	NULL

Preparation	NULL
of	NULL
mouse	NULL
cell	NULL
suspen-	NULL
sions	NULL
.	NULL

In	NULL
Selected	NULL
Methods	NULL
in	NULL
Cellular	NULL
Immunology	NULL
.	NULL

BB	NULL
.	NULL

Mishell	NULL
,	NULL
and	NULL
S.M	NULL
.	NULL

Shiigi	NULL
,	NULL
editors	NULL
.	NULL

W.H	NULL
.	NULL

Freeman	NULL
,	NULL
New	NULL
York	NULL
.	NULL

21-22	NULL
.	NULL

Functional	NULL
Myc-Max	NULL
Heterodimer	NULL
and	NULL
Apoptosis	NULL
in	NULL
T	NULL
Cell	NULL
Hybridomas	NULL

